These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 17637172)

  • 21. [A new inclusion complex of silibinin and beta-cyclodextrins: in vitro dissolution kinetics and in vivo absorption in comparison with traditional formulations].
    Arcari M; Brambilla A; Brandt A; Caponi R; Corsi G; Di Rella M; Solinas F; Wachter WP
    Boll Chim Farm; 1992 May; 131(5):205-9. PubMed ID: 1445687
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel tocolytic agent: effects of letrozole on gestational length and parturition time.
    Kafali H; Iriadam M
    Am J Perinatol; 2007 May; 24(5):323-6. PubMed ID: 17516308
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preclinical pharmacokinetic evaluation of resveratrol trimethyl ether in sprague-dawley rats: the impacts of aqueous solubility, dose escalation, food and repeated dosing on oral bioavailability.
    Lin HS; Ho PC
    J Pharm Sci; 2011 Oct; 100(10):4491-500. PubMed ID: 21520090
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Formulation-dependent toxicokinetics explains differences in the GI absorption, bioavailability and acute neurotoxicity of deltamethrin in rats.
    Kim KB; Anand SS; Muralidhara S; Kim HJ; Bruckner JV
    Toxicology; 2007 May; 234(3):194-202. PubMed ID: 17448586
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High performance liquid chromatography method for the pharmacokinetic study of bicalutamide SMEDDS and suspension formulations after oral administration to rats.
    Singh AK; Chaurasiya A; Jain GK; Awasthi A; Asati D; Mishra G; Khar RK; Mukherjee R
    Talanta; 2009 Jun; 78(4-5):1310-4. PubMed ID: 19362193
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preclinical comparison of intravenous melphalan pharmacokinetics administered in formulations containing either (SBE)7 m-β-cyclodextrin or a co-solvent system.
    Koltun M; Morizzi J; Katneni K; Charman SA; Shackleford DM; McIntosh MP
    Biopharm Drug Dispos; 2010 Nov; 31(8-9):450-4. PubMed ID: 20865695
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The oral mTOR inhibitor RAD001 (everolimus) in combination with letrozole in patients with advanced breast cancer: results of a phase I study with pharmacokinetics.
    Awada A; Cardoso F; Fontaine C; Dirix L; De Grève J; Sotiriou C; Steinseifer J; Wouters C; Tanaka C; Zoellner U; Tang P; Piccart M
    Eur J Cancer; 2008 Jan; 44(1):84-91. PubMed ID: 18039566
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lipid-based formulations to enhance oral bioavailability of the poorly water-soluble drug anethol trithione: effects of lipid composition and formulation.
    Han SF; Yao TT; Zhang XX; Gan L; Zhu C; Yu HZ; Gan Y
    Int J Pharm; 2009 Sep; 379(1):18-24. PubMed ID: 19508887
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy, toxicity, and quality of life in older women with early-stage breast cancer treated with letrozole or placebo after 5 years of tamoxifen: NCIC CTG intergroup trial MA.17.
    Muss HB; Tu D; Ingle JN; Martino S; Robert NJ; Pater JL; Whelan TJ; Palmer MJ; Piccart MJ; Shepherd LE; Pritchard KI; He Z; Goss PE
    J Clin Oncol; 2008 Apr; 26(12):1956-64. PubMed ID: 18332474
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative bioavailability of letrozole under fed and fasting conditions in 12 healthy subjects after a 2.5 mg single oral administration.
    Sioufi A; Sandrenan N; Godbillon J; Trunet P; Czendlik C; Howald H; Pfister C; Ezzet F
    Biopharm Drug Dispos; 1997 Aug; 18(6):489-97. PubMed ID: 9267682
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Folate Conjugated Hybrid Nanocarrier for Targeted Letrozole Delivery in Breast Cancer Treatment.
    Hemati Azandaryani A; Kashanian S; Derakhshandeh K
    Pharm Res; 2017 Dec; 34(12):2798-2808. PubMed ID: 29110284
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A phase I and pharmacokinetic study of lapatinib in combination with letrozole in patients with advanced cancer.
    Chu QS; Cianfrocca ME; Goldstein LJ; Gale M; Murray N; Loftiss J; Arya N; Koch KM; Pandite L; Fleming RA; Paul E; Rowinsky EK
    Clin Cancer Res; 2008 Jul; 14(14):4484-90. PubMed ID: 18628463
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improving glyburide solubility and dissolution by complexation with hydroxybutenyl-beta-cyclodextrin.
    Klein S; Wempe MF; Zoeller T; Buchanan NL; Lambert JL; Ramsey MG; Edgar KJ; Buchanan CM
    J Pharm Pharmacol; 2009 Jan; 61(1):23-30. PubMed ID: 19126293
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular encapsulation of thalidomide with sulfobutyl ether-7 beta-cyclodextrin for immediate release property: enhanced in vivo antitumor and antiangiogenesis efficacy in mice.
    Kale R; Tayade P; Saraf M; Juvekar A
    Drug Dev Ind Pharm; 2008 Feb; 34(2):149-56. PubMed ID: 18302033
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of hydrophobins in formulation of water insoluble drugs for oral administration.
    Haas Jimoh Akanbi M; Post E; Meter-Arkema A; Rink R; Robillard GT; Wang X; Wösten HA; Scholtmeijer K
    Colloids Surf B Biointerfaces; 2010 Feb; 75(2):526-31. PubMed ID: 19836932
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of pH and water-soluble polymers on the aqueous solubility of nimesulide in the absence and presence of beta-cyclodextrin derivatives.
    Alexanian C; Papademou H; Vertzoni M; Archontaki H; Valsami G
    J Pharm Pharmacol; 2008 Nov; 60(11):1433-9. PubMed ID: 18957163
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of aromatase inhibitors letrozole and anastrazole on bone metabolism and steroid hormone levels in intact female rats.
    Kumru S; Yildiz AA; Yilmaz B; Sandal S; Gurates B
    Gynecol Endocrinol; 2007 Oct; 23(10):556-61. PubMed ID: 17952760
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Physicochemical, in silico and in vivo evaluation of a danazol-beta-cyclodextrin complex.
    Jadhav GS; Vavia PR
    Int J Pharm; 2008 Mar; 352(1-2):5-16. PubMed ID: 18023545
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relative bioavailability of two forms of a novel water-soluble coenzyme Q10.
    Zmitek J; Smidovnik A; Fir M; Prosek M; Zmitek K; Walczak J; Pravst I
    Ann Nutr Metab; 2008; 52(4):281-7. PubMed ID: 18645245
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Supramolecular nanoencapsulation as a tool: solubilization of the anticancer drug trans-dichloro(dipyridine)platinum(II) by complexation with beta-cyclodextrin.
    Horvath G; Premkumar T; Boztas A; Lee E; Jon S; Geckeler KE
    Mol Pharm; 2008; 5(2):358-63. PubMed ID: 18281942
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.